Advertise on podcast: Real World Leadership

How have investments in the life sciences space changed over the last few years? Sara Michelmore from Milestone Advisors reflects and shares advice.

Getting More Resources. Show Them the Data. by The Vanguard Network

The majority of active pharmaceutical ingredients come from other countries. Whose responsibility is it to secure America’s future in healthcare innovation? Dr. Jeremy Levin is clear: everyone.

Resilience and focus. Neuroscientist Benjamin Bargetzi shares how these two qualities can help anyone manage trauma, leverage AI, and become better leaders.

What does a GC have that the average lawyer may not? Learn what longtime GC Heather White looks for, plus her take on how COVID and AI changed the game.

Is verbal identity as important to branding as graphics and other visuals? Find out as The Vanguard Network speaks to strategist and veteran copywriter Jim Larkin.

In this episode of Pharmaceutical Executive’s podcast series Leading Edge With Ken Banta, The Vanguard Network founder and CEO is joined by branding strategist Andy Milligan, founding partner of The Caffeine Partnership, where the duo examine why life sciences companies urgently need to rethink how they build, protect, and communicate their brands. From the erosion of trust in pharma to the disconnect between scientific innovation and patient experience, the discussion surfaces a core challenge: companies must evolve beyond product-centric messaging to patient-centric storytelling and emotional connection. The conversation also probes the unique tensions in healthcare — where cost, value, and trust collide — and outlines how leaders can retool brand engagement across stakeholders, including physicians, patients, payers, and investors. Highlights of the discussion with Michael Christel, MJH Life Sciences group managing editor, include: - Relevance + consistency = brand durability. Milligan underscores that strong brands evolve with customers while maintaining a clear, consistent identity — something many biopharma companies struggle to balance. - Trust is pharma’s defining — and fragile — currency. From pricing scrutiny to commercialization skepticism, the industry faces a persistent trust gap that branding must actively address. - The science-to-experience disconnect. While early-stage innovation earns high trust, that credibility often erodes at commercialization, creating a messaging challenge around value, cost, and access. - Storytelling as a strategic lever, especially in rare disease. Patient-centric narratives and simpler, more emotive messaging can bridge gaps across stakeholders and strengthen engagement across the care journey. Milligan advises CEOs and senior management teams on strategies for developing and exploiting brands and growing their business. He is a regular speaker at conferences internationally and has made frequent appearances in media, including on BBC, Sky, and CNN. Milligan has also published six best-selling books.

As general counsel, Tom Sabatino is very familiar with business upheaval. He tells the Vanguard Network why current upsets are different, and how leaders can keep cool.

During business disruptions, Anika Therapeutics CEO Cheryl Blanchard takes a no-nonsense approach with C-suite leaders. Find out how she does it without creating a toxic workplace culture.

Business psychologist Dr. Sharon Melnick says the C-suite isn’t immune to burnout. Learn the root cause of simultaneous exhaustion and overwhelm, as well as the fix.

In this episode, hosts Nate Beaver and Kyle Faget examine the tension between federal and state authority in healthcare regulation. They explore when the FDA has the final say—and when states step in, highlighting real-world examples and legal implications for companies, counsel, and innovators navigating this evolving landscape.

Ken Banta, founder and CEO of the Vanguard Network, is a recognized expert in leadership and organizational change. With a rich background as a journalist—covering pivotal events like the Eastern European revolutions for Time magazine—Ken transitioned into corporate leadership, helping guide major turnarounds at companies such as Pharmacia and Bausch & Lomb. His latest book, Seeing Around Corners, gathers lessons from top leaders and is designed to inspire everyone, from emerging professionals to global executives. Ken’s perspective on leadership is shaped by witnessing ordinary people drive extraordinary change, often guided by unexpected leaders like Vaclav Havel. These experiences reinforced his belief that leadership isn’t just for those at the top; anyone, regardless of background or title, can play a vital role. True leaders are consistent in their purpose, adaptable, and agile—qualities that matter as much in everyday life as in the boardroom. Ken’s key takeaway is simple: leadership is for everyone. Whether you’re leading a team or contributing as an individual, you can make an impact by being clear on your purpose, staying flexible in your approach, and staying connected to those around you. Embrace your own ability to lead and remember—often, the most lasting change comes from ordinary people stepping up in extraordinary ways.

In this episode of Your Partner In Success Radio, Denise Griffitts speaks with Ken Banta, a leadership advisor and founder of The Vanguard Network. Drawing on insights from his book Seeing Around Corners, Ken explains how leaders can navigate disruption and crisis while keeping their organizations aligned and resilient. The discussion highlights common mistakes executives make, the importance of communication, and how to anticipate change before it arrives. Listeners will gain actionable insights into making better decisions, strengthening their leadership presence, and guiding their teams through transformation.

Timothy Chow, managing director and senior advisor at Patrick Doerr LLP, visits the Vanguard Network to share practical uses for AI, including applications for corporate problem-solving.

Wes Adams is an organizational psychologist and author who studies what makes our work matter to us. Unsurprisingly, leadership has a lot to do with it.